Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies
A Acosta, A Ciapponi, M Aaserud… - Cochrane Database …, 2014 - cochranelibrary.com
Background Pharmaceuticals are important interventions that could improve people's health.
Pharmaceutical pricing and purchasing policies are used as cost‐containment measures to …
Pharmaceutical pricing and purchasing policies are used as cost‐containment measures to …
Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
M Aaserud, AT Dahlgren, JP Kösters… - The Cochrane …, 2006 - europepmc.org
Background Pharmaceuticals can be important for people's health. At the same time drugs
are major components of health care costs. Pharmaceutical pricing and purchasing policies …
are major components of health care costs. Pharmaceutical pricing and purchasing policies …
[图书][B] WHO guideline on country pharmaceutical pricing policies
World Health Organization - 2020 - apps.who.int
Country Pharmaceutical Pricing Policies Page 1 ACCESS TO MEDICINES, VACCINES AND
PHARMACEUTICALS WHO Guideline on Country Pharmaceutical Pricing Policies WHO guideline …
PHARMACEUTICALS WHO Guideline on Country Pharmaceutical Pricing Policies WHO guideline …
Pharmaceutical policies: effects of financial incentives for prescribers
H Sturm, A Austvoll-Dahlgren, M Aaserud… - Cochrane Database …, 2007 - research.rug.nl
Background Pharmaceuticals, while central to medical therapy, pose a significant burden to
health care budgets. Therefore regulations to control prescribing costs and improve quality …
health care budgets. Therefore regulations to control prescribing costs and improve quality …
Determinants of drug prices: a systematic review of comparison studies
JMJ Daalen, A den Ambtman, M Van Houdenhoven… - BMJ open, 2021 - bmjopen.bmj.com
Objective In this systematic review on drug price comparison studies, we report on recent
determinants of drug prices in a national and international context to facilitate regulation of …
determinants of drug prices in a national and international context to facilitate regulation of …
A systematic review of pharmaceutical pricing policies in developing countries
N Abdel Rida, MI Mohamed Ibrahim… - Journal of …, 2017 - academic.oup.com
Objective A systematic review was conducted to summarize government strategies aimed at
controlling pharmaceutical prices in developing countries and their effects on relevant …
controlling pharmaceutical prices in developing countries and their effects on relevant …
Policy options for pharmaceutical pricing and purchasing: issues for low-and middle-income countries
TA Nguyen, R Knight, EE Roughead… - Health Policy and …, 2015 - academic.oup.com
Pharmaceutical expenditure is rising globally. Most high-income countries have exercised
pricing or purchasing strategies to address this pressure. Low-and middle-income countries …
pricing or purchasing strategies to address this pressure. Low-and middle-income countries …
Pharmaceutical policies: effects of financial incentives for prescribers
Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …
grow in countries of all income categories. Policy‐makers are under pressure to control …
Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines
VL Luiza, LA Chaves, RM Silva… - Cochrane Database …, 2015 - cochranelibrary.com
Background Growing expenditures on prescription medicines represent a major challenge
to many health systems. Cap and co‐payment policies are intended as an incentive to deter …
to many health systems. Cap and co‐payment policies are intended as an incentive to deter …
Pharmaceutical policies: effects of restrictions on reimbursement
CJ Green, M Maclure, PM Fortin… - Cochrane Database …, 1996 - cochranelibrary.com
Background Public policy makers and benefit plan managers need to restrain rising
pharmaceutical drug costs while preserving access and optimizing health benefits …
pharmaceutical drug costs while preserving access and optimizing health benefits …